CIK 0002093101
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Atrium Therapeutics, Inc.
Sign in to watch- Ticker
- RNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 394639499
- Phone
- +1 619-876-0700
- Business address
- 10578 SCIENCE CENTER DRIVE, SUITE 125, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Flanagan W. Michael Director | Shares withheld for taxes | −22,812 | $8.95 | $204K | 31,974 |
| 2026-02-27 | Flanagan W. Michael Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 1 of 1 · 2 trades